These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6988805)

  • 41. [The desogestrel-ethinyl estradiol combination and overweight: current data].
    Rubio Lotvin B
    Ginecol Obstet Mex; 1995 Nov; 63():483-6. PubMed ID: 8537039
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Estrogens and vascular risk].
    Corvol P; Ménard J; Milliez P
    Rev Prat; 1979 Apr; 29(21):1755-8, 1761-5. PubMed ID: 472623
    [No Abstract]   [Full Text] [Related]  

  • 43. The physiological action of progesterone and the pharmacological effects of progestogens--a short review.
    Neumann F
    Postgrad Med J; 1978; 54 Suppl 2():11-24. PubMed ID: 368741
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Estrogens, progestins and vascular risks].
    de Lignières B
    Rev Prat; 1993 Dec; 43(20):2631-7. PubMed ID: 8146563
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of oral contraceptives on blood vessels and migraine (author's transl)].
    Carroll JD; Grant EC
    Klin Monbl Augenheilkd; 1973 Aug; 163(2):212-5. PubMed ID: 4761737
    [No Abstract]   [Full Text] [Related]  

  • 46. [Contraception for the diabetic woman].
    Arlot S; Mesmacque A; Lalau JD; Quichaud J
    Fertil Contracept Sex; 1988 Nov; 16(11):921-6. PubMed ID: 12282829
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Contraceptives and the liver].
    Schmid M
    Leber Magen Darm; 1981 Sep; 11(5):216-26. PubMed ID: 7300550
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The expediency of using natural oestrogens in combined oral contraceptive tablets].
    Kovacs L; Zalanyi S; Tekulics A; Sas M
    Orvoskepzes; 1983 Mar; 58(2):99-103. PubMed ID: 12312969
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Initial action of synthetic sexual steroids on serum-haptoglobin concentration (author's transl)].
    Klinger G; Günther E; Günther M; Gerlach D
    Zentralbl Gynakol; 1981; 103(1):41-5. PubMed ID: 7223167
    [TBL] [Abstract][Full Text] [Related]  

  • 50. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Major vascular complications during treatment with oral contraceptives and retrospective discovery of idiopathic hyperlipemia. 9 cases].
    de Gennes JL; Turpin G; Truffert J
    Presse Med (1893); 1970 Mar; 78(12):541-6. PubMed ID: 5439189
    [No Abstract]   [Full Text] [Related]  

  • 52. [Synthetic progestogens and phlebopathies].
    Degrassi R
    Minerva Med; 1971 Feb; 62(16):743-4. PubMed ID: 5549395
    [No Abstract]   [Full Text] [Related]  

  • 53. [Possible interference of synthetic estroprogestins with thyroid hormone production].
    Paggi A; Leri O; Evangelista M; Manfredi F; Coarelli C; Loiacono C; Cassone R
    Clin Ter; 1981 Aug; 98(4):349-63. PubMed ID: 7285541
    [No Abstract]   [Full Text] [Related]  

  • 54. Body weight change during use of a monophasic oral contraceptive containing 20 microg ethinylestradiol and 75 microg gestodene with a comparison of the women who completed versus those who prematurely discontinued intake.
    Endrikat J; Gerlinger C; Cronin M; Wessel J; Ruebig A; Rosenbaum P; Düsterberg B
    Eur J Contracept Reprod Health Care; 2001 Dec; 6(4):199-204. PubMed ID: 11848649
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Vascular "remodeling"].
    Ponte E; Cafagna D; Burri R
    Minerva Med; 1997 Apr; 88(4):143-9. PubMed ID: 9182257
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Births following oral contraceptive failures.
    Harlap S; Eldor J
    Obstet Gynecol; 1980 Apr; 55(4):447-52. PubMed ID: 7366901
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of combined synthetic progestins on blood coagulation properties and alpha 2-glycoprotein content].
    Lutsik LA
    Sov Med; 1981; (2):52-5. PubMed ID: 7244809
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Have pills with a low dose of progestogen been proven metabolically harmless? (author's transl)].
    Cathelineau G
    Contracept Fertil Sex (Paris); 1982 Jan; 10(1):11-3. PubMed ID: 12264005
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of estrogens on vascular proliferation].
    Perrot-Applanat M
    Therapie; 1999; 54(3):333-7. PubMed ID: 10500447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The eye and hormones: vascular disorders associated with combined oral contraceptives and pregnancy].
    Villatte-cathelineau B
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):147-52. PubMed ID: 12280201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.